by Michael Tchong | Aug 24, 2023 | Body Aesthetics
Update: We have been testing the semaglutide drug Ozempic. Our first participant, Tester 1, is a female Las Vegas resident in her 50s who has completed four doses of 0.25 mg and is preparing to administer her final two injections of 0.5 mg contained in the initial...
by Michael Tchong | Jan 12, 2023 | Trends
In August 2017, the FDA announced new rules governing the sale and distribution of over-the-counter (OTC) hearing aids. Unfortunately, it took the government agency fully five years to issue its final ruling on Aug. 16, 2022. Before this long-awaited ruling, only...
by Michael Tchong | Jan 8, 2023 | Trends
Not long ago, the world of audio was dominated by such Japanese brands as Kenwood, Marantz, Pioneer, Sansui, Sony, and Technics. These companies were considered audio innovators. That’s no longer the case due to the disruption in the market caused by the innovation of...
by Michael Tchong | Jul 12, 2022 | Wallet
Thought the crypto boom was over? Gibraltar-based digital asset management platform Gnosis Safe has rebranded as Safe and raised $100 million in funding. The round was led by crypto fund 1kx and nine other investors, including Tiger Global, A&T Capital, Blockchain...
by Michael Tchong | Jun 11, 2022 | Tools
Jack Dorsey’s TBD, a subsidiary of Block (aka Square), announced it’s building “Web5: An extra decentralized web platform.” In July 2021, TBD launched with the aim of creating “an open developer platform” focused on decentralized finance and Bitcoin. Its website now...
